Planners are finalizing programming for the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, to be held at the San Diego Convention Center, October 1-4, 2023, which will offer more than 2,000 research presentations and 300 scientific abstracts and nearly 200 exhibitors.
/PRNewswire/ BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet.
BERGEN, Norway, Feb. 16, 2023 /PRNewswire/ BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical
- Distinguished global experts appointed to strengthen bemcentinib development in STK11m NSCLC - BERGEN, Norway, Feb. 2, 2023 /PRNewswire/ BerGenBio ASA (OSE: BGBIO), a clinical-stage
/PRNewswire/ BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet.